Position in ROIV
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$299,942,848
+$41,549,188 QoQ
Shares Held
8,475,356
-9.1% QoQ
Ownership
1.17%
of shares outstanding
% of Portfolio
11.47%
of 13F equity value
Holder Rank
#13
of 494 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Derivatives in ROIV
reported options exposure · as of Jun 30, 2026CallValue
$52,469,214
CallShares
1,482,600
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Two Seas Capital LP holds $827,767,805 across 6 Biotechnology names. ROIV ranks #1 (36.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
This page
|
8,475,356 | $299,942,848 | |
| 2 | NKTR |
Nektar Therapeutics
|
3,092,234 | $215,868,855 | |
| 3 | IMVT |
Immunovant, Inc.
|
3,148,505 | $121,311,897 | |
| 4 | ABUS |
Arbutus Biopharma Corp
|
19,095,583 | $91,658,798 | |
| 5 | QURE |
uniQure N.V.
|
1,441,410 | $66,391,344 | |
| 6 | ABVX |
Abivax S.A.
|
244,590 | $32,594,063 |
All Filings in ROIV
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $52,469,214 | 1,482,600 | Call | Sole | 2026-08-12 | |
| 2026-06-30 | $299,942,848 | 8,475,356 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $258,393,660 | 9,328,291 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $20,284,710 | 732,300 | Call | Sole | 2026-05-15 | |
| 2025-12-31 | $52,850,350 | 2,435,500 | Call | Sole | 2026-02-11 | |
| 2025-12-31 | $212,484,034 | 9,791,891 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $36,849,115 | 2,435,500 | Call | Sole | 2025-11-14 | |
| 2025-09-30 | $177,840,501 | 11,754,164 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $119,439,910 | 10,598,040 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $102,275,337 | 10,136,307 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $120,285,156 | 10,167,807 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $112,225,265 | 9,724,893 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $109,069,335 | 10,318,764 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $83,585,878 | 7,930,349 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $95,547,344 | 8,508,223 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $92,449,909 | 7,915,232 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $79,728,677 | 7,909,591 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $57,616,449 | 7,807,107 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $51,219,415 | 6,410,440 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $18,900,401 | 5,869,690 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $13,918,732 | 3,419,836 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $3,986,120 | 806,907 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $3,135,333 | 311,045 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||